Medicine & Life Sciences
Central Serous Chorioretinopathy
100%
Network Meta-Analysis
94%
Photochemotherapy
24%
Lasers
20%
Vascular Endothelial Growth Factor A
16%
Confidence Intervals
13%
Eplerenone
9%
Natural History
9%
Lutein
8%
Ranibizumab
8%
MEDLINE
8%
Visual Acuity
8%
Ocular Vision
8%
Retinal Pigment Epithelium
7%
Bevacizumab
7%
Randomized Controlled Trials
6%
Therapeutics
6%
Odds Ratio
6%
Eye
5%
Retina
5%
Krypton
5%
Registries
5%
aflibercept
4%
Carbonic Anhydrase Inhibitors
4%
Observation
4%
Mifepristone
4%
Spironolactone
4%
Argon
3%
Middle East
3%
South America
3%
Far East
3%
Intravitreal Injections
3%
Choroid
3%
Pylorus
3%
North America
3%
Consensus
3%
Uncertainty
2%
Patient Selection
2%
Atrophy
2%
Language
2%
Data Analysis
2%
Placebos
2%
Clinical Trials
2%
Databases
1%
Safety
1%
Recurrence
1%